ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial

BACKGROUND: SARS-CoV-2 infection is associated with a significant risk of hospitalisation, death, and prolonged impact on quality of life. Evaluation of new treatment options and optimising therapeutic management of people hospitalised with SARS-CoV-2 infection remains essential, but rapid changes i...

Descripción completa

Detalles Bibliográficos
Autores principales: Denholm, Justin T., Venkatesh, Balasubramanian, Davis, Joshua, Bowen, Asha C., Hammond, Naomi E., Jha, Vivekanand, McPhee, Grace, McQuilten, Zoe, O’Sullivan, Matthew V. N., Paterson, David, Price, David, Rees, Megan, Roberts, Jason, Jones, Mark, Totterdell, James, Snelling, Thomas, Trask, Nanette, Morpeth, Susan, Tong, Steven YC
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747535/
https://www.ncbi.nlm.nih.gov/pubmed/36514143
http://dx.doi.org/10.1186/s13063-022-06929-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747535/
https://www.ncbi.nlm.nih.gov/pubmed/36514143
http://dx.doi.org/10.1186/s13063-022-06929-y

Ejemplares similares